Advanced Accele. Ads (AAAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AAAP | CRNX | PTCT | ||
| Company | Advanced Accele. Ads | Crinetics Pharmaceuticals Inc | Ptc Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 81.63 | 53.93 | 45.56 | ||
| High | 82.05 | 54.78 | 46.15 | ||
| Low | 81.50 | 53.15 | 44.95 | ||
| Last | 81.63 | 53.94 | 45.35 | ||
| Change | +0.13 | -0.02 | -0.21 | ||
| % Change | +0.16% | -0.04% | -0.46% | ||
| Volume | 12,100 | 150,300 | 185,800 | ||
| 20-Day Average Volume | 103,245 | 708,020 | 882,005 | ||
| Previous Close | 81.50 | 53.96 | 45.56 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 81.69 | 55.94 | 47.43 | ||
| 20-Day Raw Stochastic | 60.92% | 32.81% | 19.76% | ||
| 20-Day Relative Strength | 55.42% | 45.89% | 51.30% | ||
| Weighted Alpha | +126.00 | +35.85 | +70.27 | ||
| Today's Opinion | N/A | 24% Buy | 88% Buy | ||
| Previous Opinion | N/A | 24% Buy | 88% Buy | ||
| Last Month's Opinion | N/A | 80% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.84% since 02/02/18 | -2.58% since 12/17/24 | -3.55% since 12/17/24 | ||
| Low | 80.64 on 02/05/18 | 50.81 on 12/19/24 | 44.30 on 12/18/24 | ||
| High | 82.05 on 02/09/18 | 55.47 on 12/18/24 | 48.03 on 12/18/24 | ||
| 1-Month | |||||
| %Chg | -0.21% since 01/09/18 | -3.78% since 11/22/24 | +4.90% since 11/22/24 | ||
| Low | 79.90 on 02/01/18 | 50.81 on 12/19/24 | 42.94 on 11/25/24 | ||
| High | 82.74 on 01/22/18 | 60.34 on 12/11/24 | 54.16 on 12/03/24 | ||
| 3-Month | |||||
| %Chg | +0.78% since 11/09/17 | +8.27% since 09/24/24 | +24.18% since 09/24/24 | ||
| Low | 79.90 on 02/01/18 | 49.48 on 10/10/24 | 34.57 on 10/07/24 | ||
| High | 82.74 on 01/22/18 | 62.53 on 11/14/24 | 54.16 on 12/03/24 | ||
| 6-Month | |||||
| %Chg | +63.26% since 08/09/17 | +18.13% since 06/24/24 | +26.78% since 06/24/24 | ||
| Low | 44.57 on 08/31/17 | 41.01 on 06/26/24 | 28.72 on 06/28/24 | ||
| High | 82.74 on 01/22/18 | 62.53 on 11/14/24 | 54.16 on 12/03/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,590,087 | 5,004,142 | 3,513,815 | ||
| Shares Outstanding, K | 43,980 | 92,738 | 77,125 | ||
| Annual Sales | 120,980,000 | 4,010,000 | 937,820,000 | ||
| Annual Net Income | -27,990,000 | -214,530,000 | -626,600,000 | ||
| Last Quarter Sales | 43,770,000 | 400,000 | 196,790,000 | ||
| Last Quarter Net Income | -26,730,000 | -74,050,000 | -106,650,000 | ||
| 60-Month Beta | 0.61 | 0.60 | 0.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.96 on 11/12/24 | -1.39 on 11/07/24 | ||
| Latest Earnings Date | 01/04/19 | 11/12/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||